Skip to main content
. Author manuscript; available in PMC: 2019 Dec 6.
Published in final edited form as: Bioconjug Chem. 2019 Apr 15;30(5):1425–1433. doi: 10.1021/acs.bioconjchem.9b00161

Figure 5.

Figure 5.

CEST MRI enhancement by Dex10 and Dex10-ZD2 in KPC tumors and muscle (control). Mean MTRasym plots of KPC tumors, before (pre) and at 45 min after (post) injecting (a) Dex10-ZD2 or (d) Dex10. Mean MTRasym plots of a muscle ROI before and at 45 min after the injection of (b) Dex10-ZD2 or (e) Dex10. n = 6. ΔMTRasym (post-pre) of tumor and muscle in mice injected with (c) Dex10-ZD2 or (f) Dex10. n = 6. Data are presented as mean ± s.e.m.